| Symbol | DRUG |
|---|---|
| Name | BRIGHT MINDS BIOSCIENCES INC. |
| Sector | HEALTH CARE |
| Region | North America |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Address | 19 VESTRY STREET, NEW YORK, New York, 10013, United States |
| Telephone | +1 647 865-8622 |
| Fax | — |
| — | |
| Website | https://www.brightmindsbio.com |
| Incorporation | UNDEFINED |
| Incorporated On | — |
| Employees | — |
| Fiscal Year | — |
| Public Since | — |
| Exchanges | NASDAQ |
| Auditor | — |
| Audit Status | NOT PROVIDED |
| Reporting Status | — |
| CIK | 0001827401 |
| Description | Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain. The company has a portfolio of next-generation serotonin agonists designed to target neurocircuit abnormalities that are responsible for difficult to treat disorders such as resistant epilepsy, treatment resistant depression, PTSD, and pain. The companys drugs have been designed to potentially retain the powerful therapeutic aspects of psychedelic and other serotonergic compounds, while minimizing the side effects, thereby creating superior drugs to first-generation compounds, such as psilocybin. Additional info from NASDAQ: |
New Form SCHEDULE 13G/A - BRIGHT MINDS BIOSCIENCES INC. <b>Filed:</b> 2026-04-30 <b>AccNo:</b> 0000929638-26-001709 <b>Size:</b> 9 KB
Read moreNew Form SCHEDULE 13G/A - BRIGHT MINDS BIOSCIENCES INC. <b>Filed:</b> 2026-02-17 <b>AccNo:</b> 0001274173-26-000081 <b>Size:</b> 12 KB
Read moreNew Form SCHEDULE 13G/A - BRIGHT MINDS BIOSCIENCES INC. <b>Filed:</b> 2026-02-17 <b>AccNo:</b> 0001831942-26-000007 <b>Size:</b> 11 KB
Read moreNew Form SCHEDULE 13G/A - BRIGHT MINDS BIOSCIENCES INC. <b>Filed:</b> 2026-02-17 <b>AccNo:</b> 0001193125-26-054519 <b>Size:</b> 10 KB
Read moreNew Form SCHEDULE 13G/A - BRIGHT MINDS BIOSCIENCES INC. <b>Filed:</b> 2026-02-06 <b>AccNo:</b> 0001172661-26-000518 <b>Size:</b> 10 KB
Read moreNew Form FWP - BRIGHT MINDS BIOSCIENCES INC. Filed: 2026-01-07 AccNo: 0001062993-26-000098 Size: 4 MB
Read more